↑Rodriguez AM, Perron B, Lacroix L, Caillou B, Leblanc G, Schlumberger M, Bidart JM, Pourcher T (Jul 2002). "Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes". J Clin Endocrinol Metab. 87 (7): 3500–3. doi:10.1210/jc.87.7.3500. PMID12107270.
Gupta N, Martin PM, Prasad PD, Ganapathy V (2006). "SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter". Life Sci. 78 (21): 2419–25. doi:10.1016/j.lfs.2005.10.028. PMID16375929.
Miyauchi S, Gopal E, Fei YJ, Ganapathy V (2004). "Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids". J. Biol. Chem. 279 (14): 13293–6. doi:10.1074/jbc.C400059200. PMID14966140.
Lacroix L, Pourcher T, Magnon C, et al. (2004). "Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters". J. Clin. Endocrinol. Metab. 89 (3): 1423–8. doi:10.1210/jc.2003-030542. PMID15001644.
Hong C, Maunakea A, Jun P, et al. (2005). "Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8". Cancer Res. 65 (9): 3617–23. doi:10.1158/0008-5472.CAN-05-0048. PMID15867356.
Hu S, Liu D, Tufano RP, et al. (2006). "Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer". Int. J. Cancer. 119 (10): 2322–9. doi:10.1002/ijc.22110. PMID16858683.
Gopal E, Miyauchi S, Martin PM, et al. (2007). "Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract". Pharm. Res. 24 (3): 575–84. doi:10.1007/s11095-006-9176-1. PMID17245649.